 Peter DeWitt
Concepts (273)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Injuries, Traumatic | 7 | 2026 | 453 | 0.680 |
Why?
| | Gestational Age | 3 | 2021 | 989 | 0.510 |
Why?
| | Sepsis | 4 | 2026 | 664 | 0.480 |
Why?
| | Dentition, Permanent | 1 | 2016 | 5 | 0.470 |
Why?
| | Dental Anxiety | 1 | 2015 | 2 | 0.460 |
Why?
| | Tooth Abnormalities | 1 | 2016 | 16 | 0.460 |
Why?
| | Intensive Care Units, Pediatric | 4 | 2025 | 288 | 0.440 |
Why?
| | Shock, Septic | 3 | 2026 | 227 | 0.390 |
Why?
| | Intracranial Pressure | 2 | 2026 | 65 | 0.350 |
Why?
| | Bacterial Infections | 2 | 2024 | 246 | 0.340 |
Why?
| | Decision Support Systems, Clinical | 2 | 2026 | 273 | 0.310 |
Why?
| | Electronic Health Records | 4 | 2026 | 1202 | 0.310 |
Why?
| | Child | 25 | 2026 | 22739 | 0.290 |
Why?
| | Retrospective Studies | 22 | 2026 | 17325 | 0.260 |
Why?
| | Child, Preschool | 17 | 2026 | 11868 | 0.260 |
Why?
| | Machine Learning | 4 | 2026 | 587 | 0.250 |
Why?
| | Databases, Factual | 7 | 2021 | 1491 | 0.240 |
Why?
| | Parents | 1 | 2015 | 1407 | 0.240 |
Why?
| | Epidemiological Monitoring | 1 | 2026 | 70 | 0.230 |
Why?
| | Infant | 15 | 2026 | 10090 | 0.230 |
Why?
| | Adolescent | 20 | 2026 | 22573 | 0.220 |
Why?
| | Blood Culture | 1 | 2025 | 27 | 0.220 |
Why?
| | Pneumonia, Bacterial | 1 | 2025 | 113 | 0.210 |
Why?
| | Algorithms | 2 | 2024 | 1850 | 0.200 |
Why?
| | Humans | 47 | 2026 | 145763 | 0.190 |
Why?
| | Adiponectin | 1 | 2025 | 242 | 0.190 |
Why?
| | Osteophyte | 1 | 2022 | 6 | 0.190 |
Why?
| | Bacteremia | 1 | 2025 | 222 | 0.190 |
Why?
| | Hydrocortisone | 1 | 2025 | 298 | 0.190 |
Why?
| | Fractures, Compression | 1 | 2022 | 16 | 0.180 |
Why?
| | Population Surveillance | 1 | 2026 | 484 | 0.180 |
Why?
| | Seizures | 2 | 2017 | 485 | 0.180 |
Why?
| | Premature Birth | 2 | 2025 | 390 | 0.180 |
Why?
| | Female | 31 | 2026 | 79035 | 0.180 |
Why?
| | Forecasting | 2 | 2021 | 390 | 0.180 |
Why?
| | Spinal Fractures | 1 | 2022 | 76 | 0.180 |
Why?
| | Hospitalization | 5 | 2026 | 2460 | 0.170 |
Why?
| | Osteoporotic Fractures | 1 | 2022 | 62 | 0.170 |
Why?
| | Male | 27 | 2026 | 73003 | 0.170 |
Why?
| | Monitoring, Physiologic | 2 | 2026 | 289 | 0.160 |
Why?
| | Epigenomics | 1 | 2021 | 117 | 0.160 |
Why?
| | Meningioma | 1 | 2021 | 88 | 0.160 |
Why?
| | Meningeal Neoplasms | 1 | 2021 | 95 | 0.160 |
Why?
| | Lacerations | 1 | 2020 | 40 | 0.150 |
Why?
| | Hospital Mortality | 5 | 2026 | 1038 | 0.150 |
Why?
| | Neurosurgical Procedures | 2 | 2023 | 202 | 0.150 |
Why?
| | Liver Neoplasms | 2 | 2019 | 777 | 0.150 |
Why?
| | Computational Biology | 1 | 2024 | 669 | 0.150 |
Why?
| | Pneumonia | 1 | 2025 | 636 | 0.150 |
Why?
| | Specialization | 1 | 2020 | 137 | 0.140 |
Why?
| | Fetal Blood | 1 | 2021 | 327 | 0.140 |
Why?
| | Severity of Illness Index | 3 | 2022 | 2933 | 0.140 |
Why?
| | Glasgow Coma Scale | 3 | 2026 | 218 | 0.130 |
Why?
| | Neurophysiological Monitoring | 1 | 2017 | 9 | 0.130 |
Why?
| | Brimonidine Tartrate | 1 | 2017 | 10 | 0.130 |
Why?
| | Cohort Studies | 7 | 2024 | 6032 | 0.130 |
Why?
| | Thiazines | 1 | 2017 | 13 | 0.130 |
Why?
| | Timolol | 1 | 2017 | 14 | 0.130 |
Why?
| | Prostatic Neoplasms | 2 | 2014 | 981 | 0.120 |
Why?
| | Infant, Newborn | 8 | 2026 | 6464 | 0.120 |
Why?
| | Health Services Needs and Demand | 1 | 2019 | 280 | 0.120 |
Why?
| | United States | 11 | 2026 | 16123 | 0.120 |
Why?
| | Risk Factors | 9 | 2023 | 10917 | 0.120 |
Why?
| | Radiography, Panoramic | 1 | 2016 | 14 | 0.120 |
Why?
| | Pandemics | 2 | 2021 | 1711 | 0.120 |
Why?
| | Ocular Hypertension | 1 | 2017 | 70 | 0.120 |
Why?
| | Health Status Indicators | 1 | 2016 | 167 | 0.120 |
Why?
| | DNA Methylation | 1 | 2021 | 690 | 0.120 |
Why?
| | Needs Assessment | 1 | 2019 | 403 | 0.120 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2019 | 265 | 0.110 |
Why?
| | Lower Extremity | 1 | 2020 | 450 | 0.110 |
Why?
| | Glaucoma, Open-Angle | 1 | 2017 | 104 | 0.110 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2015 | 41 | 0.110 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2019 | 373 | 0.110 |
Why?
| | Rehydration Solutions | 1 | 2014 | 9 | 0.110 |
Why?
| | Endovascular Procedures | 1 | 2020 | 390 | 0.110 |
Why?
| | Isotonic Solutions | 1 | 2014 | 42 | 0.110 |
Why?
| | Cerebral Hemorrhage | 1 | 2015 | 125 | 0.110 |
Why?
| | Anticonvulsants | 1 | 2017 | 246 | 0.110 |
Why?
| | Diarrhea | 1 | 2015 | 193 | 0.110 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2015 | 107 | 0.110 |
Why?
| | Intraocular Pressure | 1 | 2017 | 330 | 0.110 |
Why?
| | Placenta | 1 | 2021 | 787 | 0.100 |
Why?
| | Infant, Premature | 2 | 2016 | 620 | 0.100 |
Why?
| | Patient Readmission | 2 | 2018 | 772 | 0.100 |
Why?
| | Prospective Studies | 6 | 2026 | 8075 | 0.100 |
Why?
| | Orbital Cellulitis | 1 | 2014 | 17 | 0.100 |
Why?
| | Cholesterol, HDL | 1 | 2015 | 201 | 0.100 |
Why?
| | Obstetrics | 1 | 2016 | 177 | 0.100 |
Why?
| | Medicare | 1 | 2020 | 904 | 0.100 |
Why?
| | Models, Biological | 1 | 2021 | 1764 | 0.100 |
Why?
| | Breast Neoplasms, Male | 1 | 2013 | 29 | 0.100 |
Why?
| | Hypertension | 1 | 2022 | 1276 | 0.100 |
Why?
| | Organ Dysfunction Scores | 2 | 2024 | 55 | 0.100 |
Why?
| | Logistic Models | 5 | 2018 | 2139 | 0.100 |
Why?
| | Electroencephalography | 1 | 2017 | 563 | 0.100 |
Why?
| | Age Distribution | 3 | 2022 | 404 | 0.100 |
Why?
| | Education, Medical, Undergraduate | 1 | 2016 | 208 | 0.100 |
Why?
| | Climate Change | 1 | 2015 | 177 | 0.100 |
Why?
| | Multiple Organ Failure | 2 | 2024 | 120 | 0.100 |
Why?
| | Young Adult | 8 | 2025 | 14251 | 0.100 |
Why?
| | SEER Program | 4 | 2014 | 230 | 0.100 |
Why?
| | Hyponatremia | 1 | 2013 | 43 | 0.100 |
Why?
| | Ophthalmologic Surgical Procedures | 1 | 2014 | 90 | 0.100 |
Why?
| | Peripheral Arterial Disease | 1 | 2020 | 509 | 0.100 |
Why?
| | Sensitivity and Specificity | 3 | 2026 | 2000 | 0.090 |
Why?
| | Radiotherapy Planning, Computer-Assisted | 1 | 2013 | 149 | 0.090 |
Why?
| | Software | 1 | 2018 | 680 | 0.090 |
Why?
| | Sulfonamides | 1 | 2017 | 583 | 0.090 |
Why?
| | Carcinoma | 1 | 2014 | 227 | 0.090 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2013 | 161 | 0.090 |
Why?
| | Temperature | 1 | 2015 | 633 | 0.090 |
Why?
| | Hypocalcemia | 1 | 2012 | 40 | 0.090 |
Why?
| | Matrix Metalloproteinase 8 | 1 | 2012 | 8 | 0.090 |
Why?
| | Decision Support Techniques | 1 | 2017 | 480 | 0.090 |
Why?
| | Triglycerides | 1 | 2015 | 520 | 0.090 |
Why?
| | Prognosis | 6 | 2017 | 4329 | 0.090 |
Why?
| | Bronchiolitis | 1 | 2013 | 87 | 0.090 |
Why?
| | Recovery of Function | 1 | 2016 | 716 | 0.090 |
Why?
| | Thyroidectomy | 1 | 2012 | 94 | 0.090 |
Why?
| | Systemic Inflammatory Response Syndrome | 2 | 2024 | 95 | 0.090 |
Why?
| | Case-Control Studies | 4 | 2025 | 3634 | 0.090 |
Why?
| | Protein Array Analysis | 1 | 2012 | 56 | 0.090 |
Why?
| | Mastectomy | 1 | 2013 | 185 | 0.090 |
Why?
| | Larynx | 1 | 2012 | 56 | 0.090 |
Why?
| | Oropharyngeal Neoplasms | 1 | 2012 | 56 | 0.090 |
Why?
| | Brain | 1 | 2024 | 2969 | 0.090 |
Why?
| | Chronic Disease | 1 | 2018 | 1812 | 0.090 |
Why?
| | Adult | 12 | 2025 | 40872 | 0.090 |
Why?
| | Positron-Emission Tomography | 1 | 2013 | 343 | 0.090 |
Why?
| | ROC Curve | 3 | 2023 | 618 | 0.090 |
Why?
| | Liver Transplantation | 1 | 2019 | 826 | 0.090 |
Why?
| | Radiotherapy, Intensity-Modulated | 1 | 2012 | 142 | 0.080 |
Why?
| | Uterine Cervical Neoplasms | 1 | 2014 | 268 | 0.080 |
Why?
| | Device Removal | 1 | 2012 | 142 | 0.080 |
Why?
| | Students, Medical | 1 | 2016 | 378 | 0.080 |
Why?
| | Wounds, Nonpenetrating | 1 | 2014 | 321 | 0.080 |
Why?
| | Lymph Nodes | 1 | 2014 | 509 | 0.080 |
Why?
| | Carcinoma, Squamous Cell | 2 | 2014 | 641 | 0.080 |
Why?
| | Critical Care | 1 | 2017 | 702 | 0.080 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1372 | 0.080 |
Why?
| | Deglutition Disorders | 1 | 2012 | 154 | 0.080 |
Why?
| | Vitamin D Deficiency | 1 | 2012 | 190 | 0.080 |
Why?
| | Esophagus | 1 | 2012 | 262 | 0.080 |
Why?
| | Insulin-Secreting Cells | 1 | 2015 | 392 | 0.080 |
Why?
| | Aging | 1 | 2021 | 1973 | 0.080 |
Why?
| | Aged | 10 | 2023 | 26215 | 0.080 |
Why?
| | Communication | 1 | 2016 | 977 | 0.070 |
Why?
| | Wounds and Injuries | 1 | 2018 | 962 | 0.070 |
Why?
| | Middle Aged | 10 | 2024 | 36302 | 0.070 |
Why?
| | Spinal Cord Injuries | 1 | 2012 | 235 | 0.070 |
Why?
| | Incidence | 3 | 2026 | 2933 | 0.070 |
Why?
| | Pregnancy | 4 | 2025 | 7215 | 0.070 |
Why?
| | Multivariate Analysis | 3 | 2017 | 1547 | 0.060 |
Why?
| | Comorbidity | 2 | 2022 | 1662 | 0.060 |
Why?
| | Decision Making | 1 | 2014 | 982 | 0.060 |
Why?
| | Tomography, X-Ray Computed | 2 | 2014 | 2770 | 0.060 |
Why?
| | Insulin Resistance | 1 | 2015 | 1244 | 0.060 |
Why?
| | Datasets as Topic | 1 | 2026 | 118 | 0.060 |
Why?
| | Obesity | 2 | 2019 | 3118 | 0.060 |
Why?
| | Neoplasm Staging | 3 | 2014 | 1474 | 0.060 |
Why?
| | Proteomics | 1 | 2012 | 1188 | 0.060 |
Why?
| | Disease Progression | 2 | 2023 | 2865 | 0.050 |
Why?
| | Aged, 80 and over | 4 | 2021 | 8346 | 0.050 |
Why?
| | Regression Analysis | 2 | 2017 | 1001 | 0.050 |
Why?
| | Cluster Analysis | 1 | 2024 | 501 | 0.050 |
Why?
| | Respiration, Artificial | 2 | 2021 | 714 | 0.050 |
Why?
| | Blood Pressure | 2 | 2022 | 1782 | 0.050 |
Why?
| | Neoplasm Grading | 2 | 2014 | 311 | 0.050 |
Why?
| | Radiotherapy | 2 | 2014 | 206 | 0.050 |
Why?
| | Models, Neurological | 1 | 2024 | 250 | 0.050 |
Why?
| | Time Factors | 3 | 2020 | 7133 | 0.050 |
Why?
| | Surveys and Questionnaires | 1 | 2015 | 6085 | 0.050 |
Why?
| | Streptococcal Infections | 1 | 2024 | 171 | 0.040 |
Why?
| | Sinusitis | 1 | 2024 | 227 | 0.040 |
Why?
| | Vital Signs | 1 | 2022 | 46 | 0.040 |
Why?
| | Blood Pressure Determination | 1 | 2022 | 145 | 0.040 |
Why?
| | Tandem Mass Spectrometry | 1 | 2025 | 572 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2026 | 1115 | 0.040 |
Why?
| | Nerve Net | 1 | 2024 | 286 | 0.040 |
Why?
| | Models, Theoretical | 1 | 2025 | 560 | 0.040 |
Why?
| | Finland | 1 | 2021 | 78 | 0.040 |
Why?
| | Survival Rate | 2 | 2017 | 2094 | 0.040 |
Why?
| | Combined Modality Therapy | 2 | 2014 | 1270 | 0.040 |
Why?
| | Bayes Theorem | 1 | 2023 | 421 | 0.040 |
Why?
| | Early Diagnosis | 1 | 2022 | 251 | 0.040 |
Why?
| | Lumbar Vertebrae | 1 | 2022 | 252 | 0.040 |
Why?
| | Perineum | 1 | 2020 | 37 | 0.040 |
Why?
| | Patient Discharge | 2 | 2017 | 995 | 0.040 |
Why?
| | Computer Simulation | 1 | 2024 | 1003 | 0.040 |
Why?
| | Respiratory Tract Infections | 1 | 2024 | 396 | 0.040 |
Why?
| | Administrative Claims, Healthcare | 1 | 2020 | 28 | 0.040 |
Why?
| | Length of Stay | 2 | 2017 | 1350 | 0.040 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2021 | 532 | 0.040 |
Why?
| | Cardiologists | 1 | 2020 | 45 | 0.040 |
Why?
| | Postoperative Complications | 1 | 2012 | 2977 | 0.040 |
Why?
| | Anal Canal | 1 | 2020 | 102 | 0.040 |
Why?
| | Radiologists | 1 | 2020 | 61 | 0.040 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2020 | 79 | 0.040 |
Why?
| | Magnetic Resonance Imaging | 2 | 2022 | 3915 | 0.040 |
Why?
| | Acute Disease | 1 | 2022 | 1036 | 0.040 |
Why?
| | Delivery, Obstetric | 1 | 2020 | 160 | 0.040 |
Why?
| | Programming Languages | 1 | 2018 | 24 | 0.030 |
Why?
| | Biomarkers | 2 | 2025 | 4302 | 0.030 |
Why?
| | Contrast Media | 1 | 2021 | 497 | 0.030 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2021 | 390 | 0.030 |
Why?
| | Trauma Severity Indices | 1 | 2017 | 115 | 0.030 |
Why?
| | Data Interpretation, Statistical | 1 | 2018 | 368 | 0.030 |
Why?
| | Stress, Psychological | 1 | 2025 | 1149 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2021 | 693 | 0.030 |
Why?
| | Tocolytic Agents | 1 | 2015 | 16 | 0.030 |
Why?
| | Magnesium Sulfate | 1 | 2015 | 18 | 0.030 |
Why?
| | Perinatal Death | 1 | 2015 | 26 | 0.030 |
Why?
| | Indomethacin | 1 | 2015 | 76 | 0.030 |
Why?
| | Drug Combinations | 1 | 2017 | 396 | 0.030 |
Why?
| | Propensity Score | 1 | 2017 | 377 | 0.030 |
Why?
| | Surgeons | 1 | 2020 | 340 | 0.030 |
Why?
| | Observer Variation | 1 | 2016 | 357 | 0.030 |
Why?
| | Chorioamnionitis | 1 | 2015 | 50 | 0.030 |
Why?
| | Video Recording | 1 | 2016 | 219 | 0.030 |
Why?
| | Ambulatory Care | 1 | 2020 | 610 | 0.030 |
Why?
| | Infant, Extremely Premature | 1 | 2015 | 68 | 0.030 |
Why?
| | Clinical Clerkship | 1 | 2016 | 109 | 0.030 |
Why?
| | Treatment Outcome | 3 | 2014 | 11793 | 0.030 |
Why?
| | Area Under Curve | 1 | 2015 | 332 | 0.030 |
Why?
| | Hospitals, Pediatric | 1 | 2018 | 558 | 0.030 |
Why?
| | Adiposity | 1 | 2019 | 532 | 0.030 |
Why?
| | Prostatectomy | 1 | 2014 | 94 | 0.020 |
Why?
| | Follow-Up Studies | 2 | 2014 | 5428 | 0.020 |
Why?
| | Glucose Tolerance Test | 1 | 2015 | 361 | 0.020 |
Why?
| | Fluid Therapy | 1 | 2014 | 155 | 0.020 |
Why?
| | Prostate-Specific Antigen | 1 | 2014 | 161 | 0.020 |
Why?
| | Mastectomy, Segmental | 1 | 2013 | 107 | 0.020 |
Why?
| | Tumor Burden | 1 | 2014 | 325 | 0.020 |
Why?
| | Educational Measurement | 1 | 2016 | 326 | 0.020 |
Why?
| | Neck Dissection | 1 | 2012 | 17 | 0.020 |
Why?
| | Confidence Intervals | 1 | 2013 | 330 | 0.020 |
Why?
| | Lymphatic Metastasis | 1 | 2014 | 336 | 0.020 |
Why?
| | Heart Rate | 1 | 2017 | 856 | 0.020 |
Why?
| | Sex Distribution | 1 | 2013 | 388 | 0.020 |
Why?
| | Organs at Risk | 1 | 2012 | 37 | 0.020 |
Why?
| | Multimodal Imaging | 1 | 2013 | 129 | 0.020 |
Why?
| | Global Health | 1 | 2015 | 403 | 0.020 |
Why?
| | Birth Weight | 1 | 2015 | 517 | 0.020 |
Why?
| | Adrenal Cortex Hormones | 1 | 2015 | 484 | 0.020 |
Why?
| | Injury Severity Score | 1 | 2014 | 599 | 0.020 |
Why?
| | Preoperative Period | 1 | 2012 | 149 | 0.020 |
Why?
| | Receptors, Progesterone | 1 | 2013 | 244 | 0.020 |
Why?
| | Psychometrics | 1 | 2016 | 731 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2014 | 971 | 0.020 |
Why?
| | Patient Admission | 1 | 2013 | 220 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1925 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2013 | 1300 | 0.020 |
Why?
| | Receptors, Estrogen | 1 | 2013 | 404 | 0.020 |
Why?
| | Cervical Vertebrae | 1 | 2012 | 169 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2014 | 1330 | 0.020 |
Why?
| | Pilot Projects | 1 | 2016 | 1897 | 0.020 |
Why?
| | Linear Models | 1 | 2012 | 849 | 0.020 |
Why?
| | Pregnancy Complications | 1 | 2015 | 603 | 0.020 |
Why?
| | Up-Regulation | 1 | 2012 | 848 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2015 | 2123 | 0.020 |
Why?
| | Phenotype | 1 | 2017 | 3170 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2016 | 3416 | 0.020 |
Why?
| | Registries | 1 | 2017 | 2410 | 0.020 |
Why?
| | Clinical Competence | 1 | 2016 | 1247 | 0.020 |
Why?
| | Sex Factors | 1 | 2013 | 2110 | 0.020 |
Why?
| | Risk Assessment | 1 | 2017 | 3752 | 0.020 |
Why?
| | Diabetes Mellitus | 1 | 2015 | 1101 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2012 | 2525 | 0.020 |
Why?
| | Body Mass Index | 1 | 2015 | 2447 | 0.010 |
Why?
| | Rats | 1 | 2012 | 5585 | 0.010 |
Why?
| | Breast Neoplasms | 1 | 2013 | 2393 | 0.010 |
Why?
| | Animals | 1 | 2012 | 38097 | 0.000 |
Why?
|
|
DeWitt's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|